Transmarket Holdings’s Apellis Pharmaceuticals APLS Stock Holding History

Transmarket Holdings’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-23,585	Closed	-$949K	–	36
2026 Q1	$949K	Buy	+23,585	New	+$508K	0.51%	23

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Transmarket Holdings's APLS Position: Q2 2026 in Review

Transmarket Holdings sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 23,585 shares — an estimated $949K sold.

Transmarket Holdings first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $949K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Transmarket Holdings reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Transmarket Holdings sold 23,585 Apellis Pharmaceuticals shares in Q2 2026, an estimated $949K.
Transmarket Holdings first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Transmarket Holdings's Apellis Pharmaceuticals position peaked at $949K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Transmarket Holdings's 13F filing for Q2 2026, filed 21 Jul 2026.